SALICYLIC ACID 12%

SALICYLIC ACID 12% was reported 1921 times

SALICYLIC ACID 12% is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BRONCHOLITHIASIS 15 0.4839
1 LICHEN NITIDUS 10 0.2857
2 ACROKERATOSIS PARANEOPLASTICA 2 0.2222
3 SERONEGATIVE ARTHRITIS 109 0.0951
4 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 60 0.0898
5 LUPUS VULGARIS 106 0.0841
6 PYODERMA STREPTOCOCCAL 2 0.0800
7 LYMPH NODE CALCIFICATION 15 0.0773
8 ECTOPIC GASTRIC MUCOSA 2 0.0667
9 CHOROIDITIS 24 0.0642
10 WHIPPLE'S DISEASE 2 0.0606
11 RETINITIS 101 0.0584
12 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 90 0.0434
13 DEEP VEIN THROMBOSIS POSTOPERATIVE 76 0.0379
14 DISLOCATION OF VERTEBRA 84 0.0368
15 SWOLLEN JOINT COUNT INCREASED 103 0.0323
16 SPERMATOZOA PROGRESSIVE MOTILITY DECREASED 5 0.0296
17 CHONDRITIS 5 0.0287
18 SELF-CONSCIOUSNESS 6 0.0236
19 PATERNAL EXPOSURE BEFORE PREGNANCY 7 0.0230
20 RHEUMATIC FEVER 102 0.0229
21 BRONCHIAL WALL THICKENING 15 0.0209
22 ACHROMOTRICHIA ACQUIRED 1 0.0204
23 BONE EROSION 66 0.0186
24 RHEUMATOID FACTOR POSITIVE 106 0.0183
25 VOGT-KOYANAGI-HARADA DISEASE 4 0.0182
26 HYPOCHOLESTEROLAEMIA 6 0.0170
27 CAFFEINE ALLERGY 1 0.0161
28 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 9 0.0160
29 JOINT DISLOCATION 167 0.0158
30 ECZEMA WEEPING 2 0.0153
31 CRIME 4 0.0152
32 CARBOHYDRATE INTOLERANCE 1 0.0147
33 WOUND INFECTION 158 0.0144
34 ACQUIRED PORPHYRIA 1 0.0141
35 HYPERCHOLESTEROLAEMIA 136 0.0141
36 CHRONIC PAPILLOMATOUS DERMATITIS 1 0.0137
37 SOFT TISSUE NECROSIS 9 0.0131
38 HYPERINSULINAEMIA 4 0.0131
39 MUSCLE INJURY 107 0.0129
40 JOINT RANGE OF MOTION DECREASED 169 0.0126
41 WALKING AID USER 81 0.0123
42 SWOLLEN JOINT COUNT 3 0.0120
43 ANTIDEPRESSANT DRUG LEVEL ABOVE THERAPEUTIC 3 0.0116
44 LUPUS-LIKE SYNDROME 103 0.0113
45 SEXUAL ABUSE 5 0.0113
46 PEMPHIGUS 139 0.0111
47 POST INFLAMMATORY PIGMENTATION CHANGE 5 0.0110
48 SPONDYLITIS 39 0.0107
49 HELICOBACTER INFECTION 109 0.0106
50 GRIP STRENGTH DECREASED 92 0.0104
51 PERICARDITIS 173 0.0103
52 GINGIVAL ATROPHY 2 0.0102
53 AMOEBIC DYSENTERY 1 0.0101
54 DUODENAL ULCER PERFORATION 75 0.0101
55 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 65 0.0100
56 BREAST CANCER STAGE III 62 0.0096
57 SPINAL FUSION SURGERY 37 0.0091
58 ANAL EROSION 1 0.0091
59 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 63 0.0088
60 GRIP STRENGTH 2 0.0087
61 RED BLOOD CELL SEDIMENTATION RATE INCREASED 96 0.0087
62 C-REACTIVE PROTEIN 8 0.0086
63 IRRITABLE BOWEL SYNDROME 178 0.0083
64 ABDOMINAL WALL MASS 1 0.0082
65 FOLLICULITIS 86 0.0082
66 PRESCRIBED UNDERDOSE 163 0.0082
67 SCIATICA 129 0.0081
68 INFECTIVE TENOSYNOVITIS 2 0.0079
69 EXOSTOSIS 69 0.0075
70 MYOGLOBINURIA 4 0.0075
71 BURSITIS INFECTIVE 4 0.0074
72 AUTOIMMUNE DISORDER 71 0.0073
73 X-RAY ABNORMAL 13 0.0073
74 HIP ARTHROPLASTY 107 0.0070
75 JOINT STIFFNESS 173 0.0066
76 FOOT DEFORMITY 73 0.0066
77 BONE SEQUESTRUM 1 0.0066
78 EYE ABSCESS 2 0.0066
79 HAND DEFORMITY 86 0.0066
80 SYNOVITIS 115 0.0064
81 AUTOIMMUNE MYOSITIS 3 0.0064
82 BLOOD PRESSURE ORTHOSTATIC 1 0.0063
83 WOUND 173 0.0062
84 PARAKERATOSIS 2 0.0062
85 KETONURIA 5 0.0061
86 PRESCRIBED OVERDOSE 115 0.0059
87 TYPE 2 DIABETES MELLITUS 192 0.0057
88 PULMONARY FIBROSIS 109 0.0057
89 PALMOPLANTAR KERATODERMA 4 0.0055
90 DRUG CLEARANCE DECREASED 7 0.0054
91 DRUG TOLERANCE DECREASED 15 0.0053
92 LOWER LIMB FRACTURE 100 0.0052
93 SKIN ULCER HAEMORRHAGE 2 0.0052
94 KNEE ARTHROPLASTY 109 0.0052
95 CHEST WALL ABSCESS 1 0.0051
96 LIVER FUNCTION TEST INCREASED 106 0.0049
97 FIBROMYALGIA 119 0.0049
98 LIVER INJURY 119 0.0048
99 SKIN ATROPHY 27 0.0047
100 CARBON MONOXIDE POISONING 2 0.0047
101 PATERNAL EXPOSURE DURING PREGNANCY 4 0.0046
102 BLOOD ETHANOL INCREASED 1 0.0045
103 CONGESTIVE HEPATOPATHY 2 0.0045
104 ENDOPHTHALMITIS 26 0.0043
105 FACET JOINT SYNDROME 14 0.0043
106 CD4 LYMPHOCYTES INCREASED 1 0.0043
107 OVERLAP SYNDROME 3 0.0043
108 IMPAIRED HEALING 140 0.0043
109 ANAEMIA MACROCYTIC 9 0.0042
110 HEPATIC CIRRHOSIS 77 0.0041
111 INCORRECT DOSAGE ADMINISTERED 20 0.0041
112 GLOSSODYNIA 91 0.0041
113 CHLAMYDIAL INFECTION 3 0.0040
114 ACETONAEMIA 1 0.0040
115 JOINT DESTRUCTION 6 0.0039
116 ONYCHOLYSIS 6 0.0038
117 PALMOPLANTAR PUSTULOSIS 2 0.0038
118 OSTEOARTHRITIS 160 0.0038
119 PSORIATIC ARTHROPATHY 153 0.0038
120 RESPIRATORY ALKALOSIS 6 0.0037
121 ATRIAL ENLARGEMENT 1 0.0037
122 INTERTRIGO 2 0.0037
123 CLINODACTYLY 1 0.0036
124 GAIT INABILITY 120 0.0036
125 BURNS FIRST DEGREE 1 0.0035
126 OSTEOPOROSIS 144 0.0035
127 URINARY TRACT INFECTION FUNGAL 2 0.0035
128 PORPHYRIA ACUTE 5 0.0035
129 UPPER RESPIRATORY TRACT INFECTION 161 0.0035
130 PERIPHERAL VENOUS DISEASE 14 0.0034
131 ACUTE ABDOMEN 5 0.0034
132 SYSTEMIC LUPUS ERYTHEMATOSUS 120 0.0034
133 ROAD TRAFFIC ACCIDENT 136 0.0032
134 BORRELIA INFECTION 1 0.0032
135 DISABILITY 62 0.0031
136 PREMATURE EJACULATION 2 0.0031
137 ONYCHOMADESIS 13 0.0031
138 ACANTHOSIS 1 0.0030
139 BLAST CELL CRISIS 1 0.0030
140 CORONARY ARTERY STENOSIS 15 0.0030
141 BLOOD TRIGLYCERIDES DECREASED 1 0.0030
142 ACUTE DISSEMINATED ENCEPHALOMYELITIS 1 0.0029
143 WHEEZING 171 0.0029
144 LIP DRY 26 0.0029
145 ANKLE ARTHROPLASTY 1 0.0028
146 INFUSION SITE REACTION 8 0.0027
147 C-REACTIVE PROTEIN INCREASED 97 0.0027
148 MULTIPLE DRUG THERAPY 2 0.0027
149 PUSTULAR PSORIASIS 9 0.0026
150 CHEMICAL BURN 3 0.0026
151 EAR INFECTION 69 0.0026
152 OEDEMA 140 0.0026
153 ASEPTIC NECROSIS BONE 2 0.0026
154 THYROID HORMONES DECREASED 2 0.0025
155 DRUG-INDUCED LIVER INJURY 78 0.0025
156 DELIRIUM 86 0.0025
157 VACCINATION COMPLICATION 2 0.0024
158 ERYTHRODERMIC PSORIASIS 2 0.0024
159 INFUSION RELATED REACTION 161 0.0024
160 ANTEPARTUM HAEMORRHAGE 1 0.0024
161 COVID-19 IMMUNISATION 2 0.0024
162 BONE SCAN ABNORMAL 1 0.0024
163 UVEITIS 31 0.0023
164 LIMB MASS 5 0.0023
165 GASTROINTESTINAL OEDEMA 4 0.0023
166 BLEPHAROSPASM 14 0.0022
167 NUCHAL RIGIDITY 2 0.0022
168 MOBILITY DECREASED 158 0.0022
169 C-REACTIVE PROTEIN ABNORMAL 14 0.0022
170 DISTURBANCE IN SEXUAL AROUSAL 2 0.0022
171 ACCIDENTAL DEATH 4 0.0022
172 CONNECTIVE TISSUE DISORDER 3 0.0021
173 BLOOD CHOLESTEROL INCREASED 97 0.0021
174 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 35 0.0021
175 EPIDERMAL NECROSIS 2 0.0021
176 ONYCHOMYCOSIS 9 0.0020
177 APPLICATION SITE ACNE 1 0.0020
178 SPUTUM RETENTION 2 0.0020
179 INJURY 138 0.0020
180 IMPAIRED SELF-CARE 4 0.0019
181 SUSPECTED SUICIDE 9 0.0019
182 OESOPHAGEAL VARICES HAEMORRHAGE 4 0.0018
183 BLADDER DILATATION 2 0.0018
184 SKIN PAPILLOMA 7 0.0017
185 COLLAGEN DISORDER 1 0.0017
186 BURSITIS 21 0.0017
187 INTRAOCULAR PRESSURE INCREASED 22 0.0017
188 NAIL DISORDER 15 0.0017
189 ACUTE LUNG INJURY 2 0.0017
190 PUSTULE 4 0.0017
191 PHYSICAL PRODUCT LABEL ISSUE 2 0.0017
192 LIVE BIRTH 14 0.0017
193 GLYCOSYLATED HAEMOGLOBIN ABNORMAL 2 0.0017
194 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 80 0.0017
195 CATARACT SUBCAPSULAR 1 0.0016
196 STAPHYLOCOCCAL SKIN INFECTION 2 0.0016
197 SENSORY DISTURBANCE 26 0.0016
198 BREAST CANCER STAGE I 15 0.0016
199 PERIPHERAL SENSORIMOTOR NEUROPATHY 2 0.0016
200 POISONING 20 0.0016
201 TROPONIN T INCREASED 2 0.0016
202 MUSCULOSKELETAL STIFFNESS 138 0.0016
203 BLOOD PRESSURE DIASTOLIC ABNORMAL 4 0.0016
204 VENTRICULAR SEPTAL DEFECT 9 0.0016
205 APPLICATION SITE WARMTH 2 0.0016
206 BLOOD CORTISOL DECREASED 1 0.0016
207 GESTATIONAL HYPERTENSION 2 0.0015
208 HEPATIC ENZYME INCREASED 104 0.0015
209 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 4 0.0015
210 BRONCHITIS VIRAL 1 0.0015
211 DERMATITIS PSORIASIFORM 3 0.0015
212 ARTHROPATHY 81 0.0015
213 ANGULAR CHEILITIS 1 0.0014
214 BREAST CANCER STAGE II 12 0.0014
215 OBSTRUCTIVE AIRWAYS DISORDER 16 0.0014
216 PSORIASIS 186 0.0014
217 ALCOHOL INTOLERANCE 1 0.0014
218 JOINT LOCK 4 0.0014
219 CONTUSION 135 0.0014
220 CALCULUS URETERIC 1 0.0014
221 INFECTION 199 0.0014
222 AMNESIA 89 0.0014
223 ELECTROCARDIOGRAM T WAVE INVERSION 3 0.0014
224 VISUAL IMPAIRMENT 168 0.0014
225 APLASTIC ANAEMIA 7 0.0013
226 BLISTER 75 0.0013
227 BRAIN STEM SYNDROME 1 0.0013
228 ULCER HAEMORRHAGE 9 0.0013
229 SUSPECTED OFF LABEL USE 6 0.0013
230 STOMATITIS 80 0.0013
231 SINUSITIS 135 0.0013
232 PROSTATITIS 4 0.0013
233 SKIN PLAQUE 11 0.0013
234 ANTICOAGULATION DRUG LEVEL BELOW THERAPEUTIC 1 0.0013
235 COMPLETED SUICIDE 108 0.0013
236 HYPERKERATOSIS 7 0.0013
237 URINE KETONE BODY PRESENT 2 0.0013
238 SKIN EROSION 4 0.0012
239 RASH VESICULAR 6 0.0012
240 BRADYARRHYTHMIA 2 0.0012
241 TACHYCARDIA 108 0.0012
242 MUSCULAR WEAKNESS 136 0.0012
243 EXPOSURE VIA INGESTION 3 0.0012
244 PRODUCT DISTRIBUTION ISSUE 11 0.0012
245 DISCOMFORT 72 0.0012
246 LOWER RESPIRATORY TRACT CONGESTION 2 0.0012
247 APTYALISM 1 0.0012
248 LAZINESS 2 0.0012
249 URTICARIA 196 0.0012
250 ATONIC SEIZURES 1 0.0012
251 HYPOAESTHESIA 174 0.0012
252 POOR QUALITY SLEEP 25 0.0012
253 SQUAMOUS CELL CARCINOMA OF SKIN 7 0.0012
254 PULMONARY CONGESTION 15 0.0011
255 HANGOVER 4 0.0011
256 MITRAL VALVE DISEASE 2 0.0011
257 OEDEMA PERIPHERAL 137 0.0011
258 PERIPHERAL SWELLING 172 0.0011
259 LARYNGOSPASM 3 0.0011
260 MYOSITIS 10 0.0011
261 BACK INJURY 12 0.0011
262 MONOCYTE COUNT INCREASED 4 0.0011
263 ERECTILE DYSFUNCTION 28 0.0011
264 CONTRAINDICATED PRODUCT ADMINISTERED 33 0.0011
265 TOXICITY TO VARIOUS AGENTS 183 0.0011
266 ADVERSE FOOD REACTION 1 0.0011
267 MATERNAL EXPOSURE TIMING UNSPECIFIED 4 0.0011
268 INFECTED SKIN ULCER 2 0.0011
269 PRODUCT LABEL CONFUSION 6 0.0010
270 JOINT SWELLING 124 0.0010
271 SWELLING 96 0.0010
272 RHEUMATOID ARTHRITIS 116 0.0010
273 ASTHMA 115 0.0010
274 OBESITY 16 0.0010
275 PLATELET COUNT ABNORMAL 6 0.0010
276 BENIGN BREAST NEOPLASM 1 0.0010
277 IMMUNE-MEDIATED HEPATITIS 2 0.0010
278 LEG AMPUTATION 4 0.0010
279 PERIPHERAL VASCULAR DISORDER 5 0.0010
280 GENERAL PHYSICAL HEALTH DETERIORATION 111 0.0010
281 PULSELESS ELECTRICAL ACTIVITY 4 0.0010
282 POLYARTHRITIS 5 0.0009
283 HYPERSENSITIVITY 176 0.0009
284 BURNS THIRD DEGREE 1 0.0009
285 BONE DEMINERALISATION 1 0.0009
286 GENERAL SYMPTOM 7 0.0009
287 BRONCHITIS 68 0.0009
288 ARTHRITIS 72 0.0009
289 HYPERTENSION 191 0.0009
290 HIGH DENSITY LIPOPROTEIN DECREASED 3 0.0009
291 CARDIAC HYPERTROPHY 1 0.0009
292 PSEUDOMEMBRANOUS COLITIS 2 0.0009
293 BRONCHIECTASIS 6 0.0009
294 PREGNANCY AFTER POST COITAL CONTRACEPTION 2 0.0009
295 WEIGHT INCREASED 198 0.0009
296 NASOPHARYNGITIS 162 0.0009
297 BRONCHOPNEUMONIA 3 0.0009
298 BLOODY DISCHARGE 1 0.0009
299 VISUAL ACUITY REDUCED 29 0.0009
300 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 2 0.0009
301 SYNOVIAL CYST 4 0.0009
302 HAEMANGIOMA 2 0.0009
303 HYPERTRANSAMINASAEMIA 6 0.0009
304 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 2 0.0009
305 RASH MACULAR 30 0.0009
306 POOR QUALITY PRODUCT ADMINISTERED 9 0.0009
307 DYSPEPSIA 84 0.0009
308 PAPULE 6 0.0009
309 MEMORY IMPAIRMENT 117 0.0009
310 THERMAL BURN 6 0.0008
311 BONE MARROW TOXICITY 1 0.0008
312 INTENTIONAL PRODUCT USE ISSUE 74 0.0008
313 APPLICATION SITE HYPERSENSITIVITY 1 0.0008
314 EAR PAIN 16 0.0008
315 COELIAC DISEASE 8 0.0008
316 DYSURIA 30 0.0008
317 APPLICATION SITE SCAR 1 0.0008
318 DRUG TOLERANCE 4 0.0008
319 DRUG INTOLERANCE 76 0.0008
320 ABDOMINAL DISCOMFORT 131 0.0008
321 SLEEP DISORDER 55 0.0008
322 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 55 0.0008
323 HEPATITIS TOXIC 2 0.0008
324 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 13 0.0008
325 ANION GAP INCREASED 1 0.0007
326 SKIN DISCOLOURATION 34 0.0007
327 WEIGHT DECREASED 206 0.0007
328 ONYCHOCLASIS 5 0.0007
329 BEZOAR 1 0.0007
330 MACULE 2 0.0007
331 SKIN FISSURES 14 0.0007
332 SELF-INJURIOUS IDEATION 3 0.0007
333 THERAPEUTIC RESPONSE DELAYED 2 0.0007
334 LOWER RESPIRATORY TRACT INFECTION 32 0.0007
335 OESOPHAGEAL STENOSIS 2 0.0007
336 RESPIRATORY SYMPTOM 2 0.0007
337 SCAB 8 0.0007
338 METABOLIC ACIDOSIS 22 0.0007
339 BLOOD CALCIUM INCREASED 6 0.0007
340 SKIN HAEMORRHAGE 10 0.0007
341 MENINGITIS ASEPTIC 3 0.0007
342 HEPATITIS CHOLESTATIC 4 0.0007
343 SCRATCH 7 0.0007
344 CONDITION AGGRAVATED 201 0.0007
345 DRUG TOXICITY 9 0.0007
346 HYPOGLYCAEMIA 32 0.0007
347 ADRENAL INSUFFICIENCY 8 0.0007
348 EYE INJURY 2 0.0007
349 KERATITIS 2 0.0007
350 ACIDOSIS 5 0.0007
351 ACCIDENTAL DRUG INTAKE BY CHILD 1 0.0007
352 HAEMOLYSIS 5 0.0006
353 MULTIPLE-DRUG RESISTANCE 2 0.0006
354 BRAIN OEDEMA 8 0.0006
355 IRIDOCYCLITIS 2 0.0006
356 PRODUCTIVE COUGH 30 0.0006
357 PAIN IN EXTREMITY 185 0.0006
358 NEUROTOXICITY 11 0.0006
359 HEART RATE DECREASED 22 0.0006
360 CHEST PAIN 116 0.0006
361 ANALGESIC DRUG LEVEL INCREASED 1 0.0006
362 EYE PAIN 35 0.0006
363 FINGER DEFORMITY 3 0.0006
364 CONFUSIONAL STATE 100 0.0006
365 MICTURITION URGENCY 7 0.0006
366 RENAL TUBULAR NECROSIS 6 0.0006
367 GAIT DISTURBANCE 116 0.0006
368 ABDOMINAL TENDERNESS 3 0.0006
369 IMMUNODEFICIENCY 9 0.0006
370 INFLAMMATION 31 0.0006
371 COAGULOPATHY 10 0.0006
372 PNEUMONIA 192 0.0006
373 SUPRAVENTRICULAR EXTRASYSTOLES 2 0.0006
374 LUNG DISORDER 29 0.0006
375 TASTE DISORDER 12 0.0006
376 ALOPECIA 116 0.0006
377 PRODUCT LABEL ISSUE 4 0.0006
378 ACCIDENT 7 0.0006
379 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 3 0.0006
380 BLOOD AMYLASE INCREASED 1 0.0006
381 WOUND COMPLICATION 2 0.0006
382 ANKLE FRACTURE 9 0.0006
383 DERMATITIS EXFOLIATIVE GENERALISED 2 0.0006
384 ALOPECIA AREATA 1 0.0006
385 TUMOUR LYSIS SYNDROME 5 0.0006
386 PRURITUS 216 0.0006
387 SKIN WEEPING 2 0.0006
388 PNEUMONIA ASPIRATION 14 0.0006
389 GALLBLADDER DISORDER 10 0.0006
390 NIGHT SWEATS 18 0.0006
391 RENAL DISORDER 26 0.0006
392 BEHAVIOUR DISORDER 3 0.0006
393 RASH PUSTULAR 4 0.0005
394 ASPIRATION 6 0.0005
395 ASTHMATIC CRISIS 2 0.0005
396 SEBORRHOEA 2 0.0005
397 PARADOXICAL DRUG REACTION 2 0.0005
398 NEURODERMATITIS 2 0.0005
399 THERAPEUTIC PRODUCT EFFECT DECREASED 24 0.0005
400 SKIN INFECTION 6 0.0005
401 BLADDER SPASM 1 0.0005
402 IMMUNE SYSTEM DISORDER 7 0.0005
403 MOVEMENT DISORDER 17 0.0005
404 SPINAL DISORDER 5 0.0005
405 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 5 0.0005
406 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 2 0.0005
407 HYPERVENTILATION 3 0.0005
408 ARTERIAL THROMBOSIS 1 0.0005
409 POST PROCEDURAL HAEMORRHAGE 6 0.0005
410 HYPOALBUMINAEMIA 4 0.0005
411 HYPOVOLAEMIA 3 0.0005
412 DECREASED APPETITE 119 0.0005
413 PROSTATOMEGALY 2 0.0005
414 ACUTE RESPIRATORY DISTRESS SYNDROME 9 0.0005
415 SKIN ODOUR ABNORMAL 2 0.0005
416 HYPOMAGNESAEMIA 7 0.0005
417 ACNE 38 0.0005
418 FUNGAL SKIN INFECTION 2 0.0005
419 VOMITING 232 0.0005
420 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 23 0.0005
421 BACK DISORDER 8 0.0005
422 EPILEPSY 15 0.0005
423 MENISCUS INJURY 3 0.0005
424 CATARACT 29 0.0005
425 SELF-MEDICATION 2 0.0005
426 LIMB DISCOMFORT 15 0.0005
427 TREATMENT FAILURE 40 0.0005
428 PAIN OF SKIN 13 0.0005
429 CARDIO-RESPIRATORY ARREST 20 0.0005
430 ALANINE AMINOTRANSFERASE ABNORMAL 1 0.0005
431 MATERNAL EXPOSURE DURING PREGNANCY 42 0.0005
432 PYREXIA 163 0.0005
433 ABSCESS LIMB 2 0.0005
434 PURULENT DISCHARGE 2 0.0005
435 SCAR 8 0.0005
436 DEVICE DEFECTIVE 8 0.0005
437 MELANOCYTIC NAEVUS 2 0.0005
438 ADVERSE EVENT 42 0.0005
439 PARONYCHIA 2 0.0005
440 WHEELCHAIR USER 2 0.0004
441 BACTERIAL TEST POSITIVE 1 0.0004
442 QUALITY OF LIFE DECREASED 6 0.0004
443 THERAPY NON-RESPONDER 20 0.0004
444 COMPUTERISED TOMOGRAM ABNORMAL 1 0.0004
445 TACHYPNOEA 6 0.0004
446 PERFORMANCE STATUS DECREASED 2 0.0004
447 SQUAMOUS CELL CARCINOMA 4 0.0004
448 GASTROINTESTINAL DISORDER 38 0.0004
449 FRACTURE 8 0.0004
450 RESPIRATORY TRACT INFECTION 11 0.0004
451 COLORECTAL CANCER METASTATIC 1 0.0004
452 PRODUCT SUPPLY ISSUE 3 0.0004
453 PRODUCT PRESCRIBING ERROR 10 0.0004
454 FLUID OVERLOAD 6 0.0004
455 NASAL CONGESTION 24 0.0004
456 DRY MOUTH 33 0.0004
457 BLOOD PRESSURE DECREASED 27 0.0004
458 APPLICATION SITE BURN 2 0.0004
459 MULTIPLE DRUG OVERDOSE 2 0.0004
460 ADVERSE DRUG REACTION 36 0.0004
461 HYPERAMMONAEMIA 2 0.0004
462 SYNCOPE 40 0.0004
463 RESPIRATORY ARREST 11 0.0004
464 HEPATIC FAILURE 12 0.0004
465 ANXIETY 113 0.0004
466 RASH 173 0.0004
467 BRAIN ABSCESS 1 0.0004
468 CHEMICAL BURN OF SKIN 1 0.0004
469 BENIGN PROSTATIC HYPERPLASIA 2 0.0004
470 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 3 0.0004
471 FAILURE TO THRIVE 2 0.0004
472 NODULE 5 0.0004
473 ARTERIAL OCCLUSIVE DISEASE 3 0.0004
474 DEPRESSION 86 0.0004
475 AREFLEXIA 1 0.0004
476 FOOD POISONING 2 0.0004
477 ALCOHOL POISONING 1 0.0004
478 ANAL FISSURE 2 0.0004
479 JAUNDICE 10 0.0004
480 GINGIVITIS 2 0.0004
481 PRURITUS GENERALISED 8 0.0004
482 NORMAL NEWBORN 2 0.0004
483 PRODUCT USE ISSUE 69 0.0004
484 CLUMSINESS 1 0.0004
485 APPLICATION SITE HAEMORRHAGE 1 0.0004
486 THERAPEUTIC RESPONSE DECREASED 22 0.0004
487 ACUTE CORONARY SYNDROME 3 0.0004
488 CELLULITIS 18 0.0004
489 DRUG USE DISORDER 3 0.0004
490 PRODUCT COMPLAINT 9 0.0004
491 PREGNANCY 7 0.0003
492 SKIN ULCER 9 0.0003
493 EXERCISE TOLERANCE DECREASED 2 0.0003
494 HYPOKALAEMIA 16 0.0003
495 ILL-DEFINED DISORDER 21 0.0003
496 COMA SCALE ABNORMAL 1 0.0003
497 MUSCULOSKELETAL PAIN 18 0.0003
498 AUTONOMIC NERVOUS SYSTEM IMBALANCE 1 0.0003
499 SPINAL PAIN 4 0.0003
500 ENERGY INCREASED 2 0.0003
501 GLUCOSE TOLERANCE IMPAIRED 2 0.0003
502 CARDIOTOXICITY 3 0.0003
503 HAEMOLYTIC ANAEMIA 3 0.0003
504 BRAIN HERNIATION 1 0.0003
505 ATYPICAL PNEUMONIA 1 0.0003
506 BLOOD PRESSURE INADEQUATELY CONTROLLED 2 0.0003
507 OROPHARYNGEAL DISCOMFORT 3 0.0003
508 ACNE CYSTIC 1 0.0003
509 OSTEOMYELITIS 6 0.0003
510 BONE MARROW DISORDER 1 0.0003
511 ARTHRALGIA 137 0.0003
512 FOETAL GROWTH RESTRICTION 2 0.0003
513 MIGRAINE 31 0.0003
514 MENTAL STATUS CHANGES 9 0.0003
515 BACTERIAL INFECTION 6 0.0003
516 PRODUCT DISPENSING ERROR 7 0.0003
517 BLOOD CREATININE DECREASED 1 0.0003
518 MULTIPLE ORGAN DYSFUNCTION SYNDROME 9 0.0003
519 PAIN 195 0.0003
520 LIVER DISORDER 14 0.0003
521 GASTRIC ULCER 6 0.0003
522 HEPATITIS 8 0.0003
523 DRUG ABUSE 26 0.0003
524 RASH PAPULAR 7 0.0003
525 RHABDOMYOLYSIS 13 0.0003
526 FEELING HOT 19 0.0003
527 APPLICATION SITE VESICLES 2 0.0003
528 ANTINUCLEAR ANTIBODY POSITIVE 1 0.0003
529 INFLAMMATORY BOWEL DISEASE 3 0.0003
530 POLYP 2 0.0003
531 HEPATOMEGALY 3 0.0003
532 NECK PAIN 17 0.0003
533 ORAL CANDIDIASIS 4 0.0003
534 RESPIRATORY DISORDER 9 0.0003
535 DYSPNOEA 170 0.0003
536 SKIN MASS 2 0.0003
537 CHOLECYSTITIS CHRONIC 2 0.0003
538 MALIGNANT MELANOMA 4 0.0003
539 POST-TRAUMATIC STRESS DISORDER 2 0.0003
540 CEREBRAL HAEMATOMA 1 0.0003
541 HYPOTHERMIA 3 0.0003
542 HEADACHE 185 0.0003
543 B-CELL LYMPHOMA 1 0.0003
544 CIRCULATORY COLLAPSE 5 0.0003
545 MATERNAL EXPOSURE BEFORE PREGNANCY 2 0.0003
546 INFARCTION 2 0.0003
547 DIZZINESS 145 0.0003
548 CERVICAL VERTEBRAL FRACTURE 1 0.0003
549 LOCALISED INFECTION 7 0.0003
550 BLOOD CREATININE ABNORMAL 1 0.0003
551 LARGE INTESTINE POLYP 2 0.0003
552 TENDERNESS 3 0.0003
553 MASS 4 0.0003
554 INJECTION SITE URTICARIA 7 0.0003
555 APPLICATION SITE REACTION 2 0.0003
556 DUODENAL ULCER 2 0.0003
557 LYMPHOCYTE COUNT DECREASED 5 0.0003
558 HAND FRACTURE 2 0.0003
559 CONJUNCTIVAL HYPERAEMIA 1 0.0003
560 BRONCHOSPASM 4 0.0003
561 TONGUE DISORDER 2 0.0003
562 DERMATITIS BULLOUS 2 0.0003
563 CLOSTRIDIUM DIFFICILE INFECTION 6 0.0003
564 OESOPHAGITIS 3 0.0003
565 PANIC ATTACK 10 0.0003
566 BLOOD PHOSPHORUS DECREASED 1 0.0003
567 UNRESPONSIVE TO STIMULI 7 0.0003
568 GAMMA-GLUTAMYLTRANSFERASE INCREASED 6 0.0003
569 ARTHROPOD BITE 2 0.0003
570 CARDIAC DYSFUNCTION 1 0.0003
571 MIDDLE INSOMNIA 5 0.0003
572 HAEMORRHAGE INTRACRANIAL 4 0.0003
573 GASTRITIS 7 0.0003
574 STATUS EPILEPTICUS 3 0.0003
575 PAROSMIA 2 0.0003
576 INTENTIONAL OVERDOSE 17 0.0003
577 AUTOIMMUNE THYROIDITIS 1 0.0003
578 RENAL FAILURE 35 0.0003
579 BLOOD URINE PRESENT 5 0.0003
580 DERMATITIS CONTACT 3 0.0003
581 COMMUNICATION DISORDER 1 0.0003
582 TINNITUS 12 0.0003
583 FREQUENT BOWEL MOVEMENTS 7 0.0003
584 SPLENOMEGALY 3 0.0003
585 SKIN LESION 7 0.0003
586 ACUTE KIDNEY INJURY 39 0.0003
587 BLOOD LACTATE DEHYDROGENASE INCREASED 4 0.0003
588 ATRIAL FLUTTER 2 0.0003
589 AZOTAEMIA 1 0.0003
590 CYTOKINE RELEASE SYNDROME 5 0.0002
591 SENSORY LOSS 2 0.0002
592 GASTROOESOPHAGEAL REFLUX DISEASE 20 0.0002
593 UNDERDOSE 18 0.0002
594 COLITIS ULCERATIVE 11 0.0002
595 ASPHYXIA 2 0.0002
596 CARDIOMEGALY 3 0.0002
597 HYPERAESTHESIA 2 0.0002
598 ANAPHYLACTOID REACTION 1 0.0002
599 TENDON RUPTURE 3 0.0002
600 HYPERCALCAEMIA 3 0.0002
601 APPLICATION SITE EXFOLIATION 1 0.0002
602 SPINAL COMPRESSION FRACTURE 2 0.0002
603 EXTRAPYRAMIDAL DISORDER 6 0.0002
604 MENSTRUAL DISORDER 2 0.0002
605 EXPOSURE DURING PREGNANCY 15 0.0002
606 VIRAL INFECTION 8 0.0002
607 ACCIDENTAL EXPOSURE 1 0.0002
608 EOSINOPHIL COUNT INCREASED 2 0.0002
609 LEUKOPENIA 12 0.0002
610 ATTENTION DEFICIT HYPERACTIVITY DISORDER 1 0.0002
611 DIABETES MELLITUS 18 0.0002
612 HAEMATURIA 8 0.0002
613 INSOMNIA 62 0.0002
614 SKIN HYPERPIGMENTATION 2 0.0002
615 DEAFNESS 6 0.0002
616 BACK PAIN 53 0.0002
617 NAUSEA 179 0.0002
618 STEVENS-JOHNSON SYNDROME 5 0.0002
619 RASH MACULO-PAPULAR 5 0.0002
620 HEAVY MENSTRUAL BLEEDING 2 0.0002
621 COVID-19 39 0.0002
622 GASTROENTERITIS VIRAL 4 0.0002
623 RASH PRURITIC 12 0.0002
624 HIDRADENITIS 2 0.0002
625 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 12 0.0002
626 INJECTION SITE REACTION 15 0.0002
627 BUNDLE BRANCH BLOCK RIGHT 1 0.0002
628 PROSTATIC SPECIFIC ANTIGEN INCREASED 3 0.0002
629 BLOOD THYROID STIMULATING HORMONE INCREASED 2 0.0002
630 MUSCLE TWITCHING 5 0.0002
631 BLOOD PRESSURE DIASTOLIC INCREASED 1 0.0002
632 IRON DEFICIENCY ANAEMIA 2 0.0002
633 INTERVERTEBRAL DISC DEGENERATION 2 0.0002
634 LACTIC ACIDOSIS 7 0.0002
635 PARAESTHESIA 34 0.0002
636 ARTHRITIS INFECTIVE 1 0.0002
637 COGNITIVE DISORDER 10 0.0002
638 ERYTHEMA 44 0.0002
639 DIARRHOEA HAEMORRHAGIC 2 0.0002
640 BURNING SENSATION 15 0.0002
641 SKIN EXFOLIATION 18 0.0002
642 PHOTOPHOBIA 4 0.0002
643 STAPHYLOCOCCAL INFECTION 7 0.0002
644 SEASONAL ALLERGY 3 0.0002
645 HYPOCALCAEMIA 4 0.0002
646 POISONING DELIBERATE 2 0.0002
647 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 11 0.0002
648 CHRONIC LYMPHOCYTIC LEUKAEMIA 1 0.0002
649 LOSS OF CONSCIOUSNESS 27 0.0002
650 LIP SWELLING 7 0.0002
651 COMA 10 0.0002
652 SINUS BRADYCARDIA 2 0.0002
653 BLOOD PRESSURE SYSTOLIC INCREASED 4 0.0002
654 OVERDOSE 44 0.0002
655 VISION BLURRED 28 0.0002
656 ACUTE MYOCARDIAL INFARCTION 6 0.0002
657 LIGAMENT SPRAIN 2 0.0002
658 COLON CANCER 3 0.0002
659 AGEUSIA 5 0.0002
660 OFF LABEL USE 175 0.0002
661 SPINAL FRACTURE 4 0.0002
662 HYPERKALAEMIA 7 0.0002
663 BRAIN INJURY 2 0.0002
664 MEDICATION ERROR 11 0.0002
665 NEUTROPHIL COUNT INCREASED 2 0.0002
666 RIB FRACTURE 4 0.0002
667 ILLNESS 20 0.0002
668 MUSCULOSKELETAL CHEST PAIN 3 0.0002
669 FEMUR FRACTURE 6 0.0002
670 DIARRHOEA 125 0.0002
671 FATIGUE 150 0.0002
672 BASAL CELL CARCINOMA 3 0.0002
673 WEIGHT FLUCTUATION 2 0.0002
674 DERMATITIS 4 0.0002
675 ANHEDONIA 5 0.0002
676 EMOTIONAL DISTRESS 23 0.0002
677 BLOOD LACTIC ACID INCREASED 1 0.0002
678 INCONTINENCE 2 0.0002
679 DRUG INTERACTION 30 0.0002
680 ULCER 3 0.0002
681 BRADYCARDIA 10 0.0002
682 ABSCESS 3 0.0002
683 HEPATIC FUNCTION ABNORMAL 7 0.0002
684 BODY HEIGHT DECREASED 2 0.0002
685 RECTAL HAEMORRHAGE 8 0.0002
686 MUSCLE SPASMS 34 0.0002
687 INCORRECT PRODUCT ADMINISTRATION DURATION 4 0.0002
688 BIPOLAR DISORDER 2 0.0002
689 SKIN LACERATION 2 0.0002
690 SEPTIC SHOCK 8 0.0002
691 TREATMENT NONCOMPLIANCE 10 0.0002
692 EYE DISORDER 6 0.0002
693 CARDIAC ARREST 15 0.0002
694 DRUG LEVEL INCREASED 3 0.0002
695 FUNGAL INFECTION 6 0.0002
696 TOOTH DISORDER 4 0.0002
697 DRY SKIN 24 0.0002
698 BLOOD CALCIUM DECREASED 2 0.0002
699 CANDIDA INFECTION 3 0.0002
700 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 32 0.0002
701 DEPRESSED LEVEL OF CONSCIOUSNESS 7 0.0002
702 FLUID RETENTION 9 0.0002
703 CHEST DISCOMFORT 18 0.0002
704 NEPHROLITHIASIS 8 0.0002
705 NEEDLE ISSUE 5 0.0002
706 DIABETES MELLITUS INADEQUATE CONTROL 3 0.0002
707 COVID-19 PNEUMONIA 2 0.0002
708 CHOLECYSTITIS 2 0.0002
709 WRIST FRACTURE 2 0.0002
710 ELECTROCARDIOGRAM QT PROLONGED 6 0.0002
711 TOOTHACHE 3 0.0002
712 FALL 55 0.0002
713 ABDOMINAL PAIN UPPER 34 0.0002
714 CRYING 6 0.0002
715 NOCTURIA 2 0.0002
716 SCHIZOPHRENIA 2 0.0002
717 PRESYNCOPE 4 0.0002
718 ALANINE AMINOTRANSFERASE INCREASED 10 0.0002
719 MUSCLE SPASTICITY 2 0.0002
720 SPINAL OPERATION 2 0.0002
721 OSTEONECROSIS OF JAW 4 0.0002
722 CYST 2 0.0002
723 APPLICATION SITE IRRITATION 2 0.0002
724 DRY EYE 8 0.0002
725 OXYGEN SATURATION DECREASED 9 0.0002
726 PRODUCT STORAGE ERROR 14 0.0002
727 ABDOMINAL PAIN 37 0.0002
728 DERMATITIS ALLERGIC 2 0.0002
729 CYSTITIS 5 0.0002
730 WHITE BLOOD CELL COUNT INCREASED 6 0.0002
731 MYDRIASIS 2 0.0002
732 GLAUCOMA 3 0.0002
733 INFUSION SITE PAIN 2 0.0002
734 ANOREXIA 2 0.0002
735 HAEMORRHOIDS 3 0.0002
736 PLATELET COUNT INCREASED 2 0.0002
737 ECZEMA 8 0.0002
738 BEDRIDDEN 2 0.0002
739 PANCREATITIS 8 0.0002
740 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
741 BLOOD PRESSURE ABNORMAL 3 0.0002
742 ADVERSE REACTION 2 0.0002
743 BLOOD PRESSURE INCREASED 23 0.0002
744 CARDIAC DISORDER 14 0.0001
745 ATRIOVENTRICULAR BLOCK COMPLETE 1 0.0001
746 PRODUCT USE IN UNAPPROVED INDICATION 37 0.0001
747 FEEDING DISORDER 3 0.0001
748 LIMB INJURY 4 0.0001
749 NEUROPATHY PERIPHERAL 14 0.0001
750 PULMONARY HYPERTENSION 3 0.0001
751 POLLAKIURIA 6 0.0001
752 APHONIA 2 0.0001
753 RENAL IMPAIRMENT 12 0.0001
754 DISSEMINATED INTRAVASCULAR COAGULATION 2 0.0001
755 LYMPHADENOPATHY 5 0.0001
756 DRUG INEFFECTIVE 186 0.0001
757 HYPOTENSION 28 0.0001
758 MALAISE 61 0.0001
759 BLOOD CREATINE PHOSPHOKINASE INCREASED 4 0.0001
760 COMPLICATION ASSOCIATED WITH DEVICE 2 0.0001
761 APATHY 2 0.0001
762 ACCIDENTAL OVERDOSE 5 0.0001
763 RESTLESSNESS 5 0.0001
764 DEVICE DIFFICULT TO USE 9 0.0001
765 LABORATORY TEST ABNORMAL 4 0.0001
766 ORAL PAIN 3 0.0001
767 HYPOAESTHESIA ORAL 2 0.0001
768 ECONOMIC PROBLEM 2 0.0001
769 OSTEOPENIA 2 0.0001
770 SEIZURE 15 0.0001
771 THYROID DISORDER 2 0.0001
772 TENDONITIS 2 0.0001
773 CONCUSSION 1 0.0001
774 URINARY TRACT INFECTION 22 0.0001
775 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 3 0.0001
776 EJECTION FRACTION DECREASED 2 0.0001
777 COUGH 36 0.0001
778 THERAPY PARTIAL RESPONDER 2 0.0001
779 AFFECTIVE DISORDER 1 0.0001
780 BLOOD ALBUMIN DECREASED 1 0.0001
781 RESPIRATORY TRACT CONGESTION 2 0.0001
782 ATRIAL FIBRILLATION 12 0.0001
783 SWELLING FACE 8 0.0001
784 OSTEONECROSIS 4 0.0001
785 GENERALISED TONIC-CLONIC SEIZURE 2 0.0001
786 BLOOD ALKALINE PHOSPHATASE INCREASED 3 0.0001
787 DEHYDRATION 16 0.0001
788 NEOPLASM MALIGNANT 8 0.0001
789 BLOOD UREA INCREASED 2 0.0001
790 HALLUCINATION 9 0.0001
791 HAEMATEMESIS 3 0.0001
792 DRUG RESISTANCE 3 0.0001
793 MUSCULOSKELETAL DISCOMFORT 2 0.0001
794 BLOOD MAGNESIUM DECREASED 1 0.0001
795 RASH GENERALISED 3 0.0001
796 MULTI-ORGAN FAILURE 2 0.0001
797 LOCAL SWELLING 2 0.0001
798 INTENTIONAL PRODUCT MISUSE 10 0.0001
799 DEVICE MALFUNCTION 8 0.0001
800 DERMATITIS ATOPIC 6 0.0001
801 COLD SWEAT 2 0.0001
802 HEAD DISCOMFORT 2 0.0001
803 LEUKOCYTOSIS 2 0.0001
804 ANAPHYLACTIC REACTION 6 0.0001
805 BLOOD GLUCOSE ABNORMAL 2 0.0001
806 FEELING COLD 3 0.0001
807 DYSGEUSIA 8 0.0001
808 SEPSIS 12 0.0001
809 APPENDICITIS 1 0.0001
810 ARTERIOSCLEROSIS 1 0.0001
811 INTESTINAL OBSTRUCTION 4 0.0001
812 CHRONIC KIDNEY DISEASE 8 0.0001
813 FEELING ABNORMAL 25 0.0001
814 CHOLESTASIS 2 0.0001
815 AFFECT LABILITY 1 0.0001
816 ASTHENIA 39 0.0001
817 ATELECTASIS 1 0.0001
818 PRODUCT QUALITY ISSUE 14 0.0001
819 BODY TEMPERATURE DECREASED 1 0.0001
820 BLADDER DISORDER 1 0.0001
821 UPPER LIMB FRACTURE 2 0.0001
822 DEVICE ISSUE 9 0.0001
823 ABORTION SPONTANEOUS 4 0.0001
824 INTENTIONAL SELF-INJURY 2 0.0001
825 PRODUCT ADMINISTRATION ERROR 2 0.0001
826 PLEURAL EFFUSION 6 0.0001
827 FOETAL EXPOSURE DURING PREGNANCY 8 0.0001
828 BODY TEMPERATURE INCREASED 2 0.0001
829 OROPHARYNGEAL PAIN 9 0.0001
830 TOOTH LOSS 2 0.0001
831 MOUTH ULCERATION 2 0.0001
832 HALLUCINATION, VISUAL 2 0.0001
833 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
834 BREAST PAIN 1 0.0001
835 IMPAIRED WORK ABILITY 2 0.0001
836 BREAST CANCER METASTATIC 1 0.0001
837 HYPOACUSIS 4 0.0001
838 SKIN CANCER 2 0.0001
839 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
840 FAECES DISCOLOURED 2 0.0001
841 CHOLELITHIASIS 3 0.0001
842 BLOOD GLUCOSE FLUCTUATION 1 0.0001
843 APPLICATION SITE PAIN 2 0.0001
844 SKIN DISORDER 3 0.0001
845 URINARY RETENTION 3 0.0001
846 THROMBOCYTOPENIA 10 0.0001
847 SOMNOLENCE 18 0.0001
848 PULMONARY OEDEMA 4 0.0001
849 ANAEMIA 17 0.0001
850 CHROMATURIA 2 0.0001
851 DRUG EXPOSURE DURING PREGNANCY 3 0.0001
852 APPLICATION SITE PRURITUS 2 0.0001
853 HAEMOGLOBIN DECREASED 9 0.0001
854 CHOLECYSTECTOMY 1 0.0001
855 GASTRIC DISORDER 3 0.0001
856 SKIN IRRITATION 4 0.0001
857 CARDIAC FAILURE 7 0.0001
858 LETHARGY 5 0.0001
859 CAESAREAN SECTION 1 0.0001
860 TREMOR 14 0.0001
861 DYSPHAGIA 8 0.0001
862 BACTERAEMIA 1 0.0001
863 SKIN BURNING SENSATION 6 0.0001
864 BLOOD PRESSURE FLUCTUATION 2 0.0001
865 BLOOD GLUCOSE DECREASED 4 0.0001
866 SUICIDE ATTEMPT 5 0.0001
867 HYPERGLYCAEMIA 3 0.0001
868 ENCEPHALOPATHY 2 0.0001
869 INFLUENZA 9 0.0001
870 INJECTION SITE ERYTHEMA 10 0.0001
871 AGGRESSION 4 0.0001
872 DRUG WITHDRAWAL SYNDROME 7 0.0001
873 DYSPNOEA EXERTIONAL 3 0.0001
874 CARDIOVASCULAR DISORDER 2 0.0001
875 RHINORRHOEA 5 0.0001
876 PALPITATIONS 9 0.0001
877 HAEMORRHAGE 8 0.0001
878 ANKYLOSING SPONDYLITIS 1 0.0001
879 ASPARTATE AMINOTRANSFERASE INCREASED 4 0.0001
880 BLINDNESS 3 0.0001
881 ACUTE HEPATIC FAILURE 1 0.0001
882 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
883 APPLICATION SITE RASH 1 0.0001
884 PROCEDURAL PAIN 2 0.0001
885 CARPAL TUNNEL SYNDROME 1 0.0001
886 RENAL FAILURE ACUTE 3 0.0001
887 INTENTIONAL DOSE OMISSION 2 0.0001
888 CARDIOGENIC SHOCK 1 0.0001
889 VAGINAL HAEMORRHAGE 3 0.0001
890 ANOSMIA 1 0.0001
891 MYOCARDIAL INFARCTION 12 0.0001
892 LIVER FUNCTION TEST ABNORMAL 2 0.0001
893 DYSSTASIA 2 0.0001
894 SURGERY 4 0.0001
895 AGITATION 5 0.0001
896 DISEASE PROGRESSION 8 0.0001
897 URINARY INCONTINENCE 2 0.0001
898 RENAL INJURY 2 0.0001
899 THROAT IRRITATION 3 0.0001
900 IRRITABILITY 4 0.0001
901 PREMATURE BABY 2 0.0001
902 VERTIGO 4 0.0001
903 NERVOUS SYSTEM DISORDER 2 0.0001
904 BONE DENSITY DECREASED 2 0.0001
905 HYPOTHYROIDISM 2 0.0001
906 HYPERHIDROSIS 8 0.0001
907 INTERSTITIAL LUNG DISEASE 3 0.0001
908 BLOOD POTASSIUM INCREASED 1 0.0001
909 DEEP VEIN THROMBOSIS 4 0.0001
910 BLOOD CREATININE INCREASED 4 0.0001
911 HEART RATE INCREASED 6 0.0001
912 THERAPEUTIC RESPONSE SHORTENED 2 0.0001
913 CEREBROVASCULAR ACCIDENT 10 0.0001
914 MYALGIA 10 0.0001
915 HOSPITALISATION 9 0.0001
916 NIGHTMARE 2 0.0001
917 NEOPLASM PROGRESSION 2 0.0001
918 ABDOMINAL DISTENSION 6 0.0001
919 SPEECH DISORDER 3 0.0001
920 AMENORRHOEA 1 0.0001
921 HYPOXIA 2 0.0001
922 DEPRESSED MOOD 3 0.0001
923 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
924 DISTURBANCE IN ATTENTION 3 0.0001
925 DRUG EFFECT INCOMPLETE 2 0.0001
926 CONSTIPATION 12 0.0001
927 BONE DISORDER 1 0.0001
928 SUICIDAL IDEATION 5 0.0001
929 EYE SWELLING 2 0.0001
930 PANCYTOPENIA 3 0.0001
931 HOT FLUSH 4 0.0001
932 BLOOD SODIUM DECREASED 1 0.0001
933 COLITIS 2 0.0001
934 INCORRECT DOSE ADMINISTERED 12 0.0001
935 DEATH 45 0.0001
936 HERPES ZOSTER 3 0.0001
937 ACUTE RESPIRATORY FAILURE 1 0.0001
938 BLADDER CANCER 3 0.0001
939 ACTIVITIES OF DAILY LIVING IMPAIRED 1 0.0001
940 BONE MARROW FAILURE 1 0.0000
941 MALIGNANT NEOPLASM PROGRESSION 5 0.0000
942 BLOOD GLUCOSE INCREASED 9 0.0000
943 PRODUCT DOSE OMISSION 3 0.0000
944 FEBRILE NEUTROPENIA 3 0.0000
945 ANGIOEDEMA 2 0.0000
946 THERAPEUTIC RESPONSE UNEXPECTED 2 0.0000
947 NO ADVERSE EVENT 8 0.0000
948 CHILLS 5 0.0000
949 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 3 0.0000
950 OCULAR HYPERAEMIA 2 0.0000
951 DISEASE RECURRENCE 2 0.0000
952 RASH ERYTHEMATOUS 2 0.0000
953 RESPIRATORY FAILURE 3 0.0000
954 CEREBRAL INFARCTION 1 0.0000
955 PRODUCT DOSE OMISSION ISSUE 12 0.0000
956 ABASIA 1 0.0000
957 UNEVALUABLE EVENT 3 0.0000
958 THERAPY CESSATION 2 0.0000
959 ACCIDENTAL EXPOSURE TO PRODUCT 4 0.0000
960 NERVOUSNESS 2 0.0000
961 APPLICATION SITE ERYTHEMA 1 0.0000
962 PROSTATE CANCER 3 0.0000
963 WHITE BLOOD CELL COUNT DECREASED 4 0.0000
964 DRUG DOSE OMISSION 6 0.0000
965 HAEMATOCHEZIA 2 0.0000
966 ABNORMAL DREAMS 1 0.0000
967 HYPONATRAEMIA 2 0.0000
968 BALANCE DISORDER 3 0.0000
969 DYSPHONIA 2 0.0000
970 BONE PAIN 2 0.0000
971 ASCITES 1 0.0000
972 APHASIA 1 0.0000
973 PULMONARY EMBOLISM 3 0.0000
974 INJECTION SITE PRURITUS 2 0.0000
975 ANGER 1 0.0000
976 PLATELET COUNT DECREASED 3 0.0000
977 CEREBRAL HAEMORRHAGE 1 0.0000
978 EPISTAXIS 2 0.0000
979 INJECTION SITE PAIN 8 0.0000
980 ABNORMAL BEHAVIOUR 1 0.0000
981 INJECTION SITE BRUISING 2 0.0000
982 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
983 BREAST CANCER 2 0.0000
984 ARRHYTHMIA 1 0.0000
985 DRUG DEPENDENCE 3 0.0000
986 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 3 0.0000
987 NEUTROPENIA 2 0.0000